endocrinology
Diabetes care

Repurposing exenatide a moneyspinner for Australian billionaire


Re-purposing the diabetes drug exenatide for use in intracranial hypertension has delivered a multimillion dollar overnight windfall for mining billionaire Andrew ‘Twiggy’ Forrest. Forrest has a 9% stake in a startup pharma company Invex Therapeutics, which raised $12m at IPO last week as its 30m shares rose by 270% in the first days of trading ...

Already a member?

Enter your email to keep reading.


OR